Related Experiment Video
Updated: Aug 6, 2026

10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Abnormal platelet trace amine profiles in migraine with and without aura
G D'Andrea1, F Granella, M Leone
1Headache Centre, Villa Margherita Hospital, Arcugnano (VI), Italy.
Cephalalgia : an International Journal of Headache
|August 5, 2006
Summary
Trace amine levels, including octopamine and synephrine, differ in migraine patients. This suggests a link between trace amine metabolism and migraine pathophysiology.
Area of Science:
- Neuroscience
- Biochemistry
Background:
- Trace amines (tyramine, octopamine, synephrine) are structurally similar to biogenic amines.
- Previous studies indicated elevated plasma trace amines in migraineurs, suggesting metabolic derangement.
- The specific role of trace amines in different migraine types requires further investigation.
Purpose of the Study:
- To investigate and compare platelet trace amine concentrations in migraine without aura (MoA) and migraine with aura (MA) patients during headache-free periods.
- To determine if trace amine levels differ between MoA, MA, and control groups.
- To further explore the hypothesis of deranged trace amine metabolism in migraine pathophysiology.
Main Methods:
- Utilized a multichannel electrochemical high-performance liquid chromatography system.
- Quantified platelet concentrations of tyramine, octopamine, and synephrine.
- Compared trace amine levels in MoA patients, MA patients, and healthy controls.
Main Results:
- Platelet trace amine concentrations were elevated in both MoA and MA groups compared to controls.
- Octopamine levels were significantly higher in MoA patients than in controls and MA patients.
- Synephrine levels were significantly higher in MA patients than in controls and MoA patients.
Conclusions:
- The distinct platelet trace amine profiles in MoA and MA suggest specific roles in different migraine subtypes.
- These findings support the hypothesis that altered tyrosine metabolism is implicated in migraine pathophysiology.
- Further research into trace amine metabolism could reveal novel therapeutic targets for migraine.
